Cavalier Investments, LLC Merck & Co., Inc. Transaction History

Cavalier Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$71.68 - $78.83 $1.28 Million - $1.4 Million	-17,790 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $258,293 - $304,243	3,751 Added 26.72%	17,790 $1.37 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $251,912 - $279,571	3,510 Added 33.34%	14,039 $1.15 Million
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $447,129 - $506,824	-6,110 Reduced 36.72%	10,529 $873,000
Q2 2020 Aug 10, 2020	BUY	$70.42 - $80.13 $1.17 Million - $1.33 Million	16,639 New	16,639 $1.29 Million
Q1 2019 May 03, 2019	SELL	$69.58 - $79.36 $1.09 Million - $1.24 Million	-15,640 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$65.24 - $75.71 $1.02 Million - $1.18 Million	15,640 New	15,640 $1.2 Million

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Cavalier Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Cavalier Investments, LLC with notifications on news.